Culturally Engaged REcovery: MOms Connected Through Native communitY

NCT06747442 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2026-07-07

No results posted yet for this study

Summary

Pregnant and postpartum American Indian and Alaska Native people (Native mothers) face a more than two-fold higher risk of maternal mortality compared to non-Hispanic White mothers. Deaths related to substance use (SU) and mental health conditions are a leading cause of preventable maternal mortality, including among Native mothers, making these conditions a strong target for reducing maternal mortality and morbidity. The objective of this study is to 1) adapt evidence-based perinatal care models that integrate pregnancy and postpartum care with SU treatment and care to meet the needs of Native mothers, and 2) assess the implementation and efficacy of that model for participants with substance use disorder who identify as Native receiving prenatal care at Sacred Circle Healthcare in Salt Lake City, Utah.

Conditions

  • Substance Use Disorders (SUD)
  • Pregnancy
  • Maternal Morbidity and Mortality
  • Cultural Adaptation

Interventions

BEHAVIORAL

Cradleboard Journey

Cradleboard Journey is an integrated perinatal substance use disorder group clinical program specifically created for Native mothers.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • University of Utah

    lead OTHER

Principal Investigators

  • Michelle Debbink, MD PhD · University of Utah

  • Adam Gordon, MD · University of Utah

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-26
Primary Completion
2028-12-31
Completion
2029-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06747442 on ClinicalTrials.gov